Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Weaning Approaches for Vasopressin in Sepsis - a Randomized Controlled Trial of Titrated Versus Abrupt Discontinuation During Stabilization of Septic Shock - WAVES Trial

NCT07067866 is registered in ClinicalTrials.gov with Hospital Nossa Senhora da Conceicao as lead sponsor.

NCT NCT07067866
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07067866 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Weaning Approaches for Vasopressin in Sepsis - a Randomized Controlled Trial of Titrated Versus Abrupt Discontinuation During Stabilization of Septic Shock - WAVES Trial
Lead sponsor
Hospital Nossa Senhora da Conceicao
Phase
Phase 3
Overall status
Recruiting
Start date
October 1, 2025
Completion date
October 1, 2028
Enrollment
82 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock